Maternal Supplementation Research Articles

Effect of supplementation to offspring during early gestation and the growing phase with different sources of fatty acids on learning and memory ability of post-weaning lambs

Abstract The objective of the current experiment was to evaluate the effects of supplementation with different dietary fatty acid profiles on the dam during the first third of gestation and on the offspring during growth on the offspring’s cognitive behavior. Seventy-nine post-weaning lambs were blocked by body weight and sex using a 2×2 factorial arrangement of treatments. The first factor (maternal supplementation; MS) was supplementation to the ewes in the first third of gestation with 1.61% Ca salts of palm fatty acid distillate (PFAD) or Ca salts enriched with eicosapentaenoic (EPA) and docosahexaenoic acids (DHA) to early pregnant ewes. The second factor (offspring supplementation; OS) was to supplement the offspring during their growing phase with diets that contained 1.48% of PFAD or Ca salts of PFAD or EPA and DHA. Ewes were housed in groups, three ewes per pen and 12 pens per treatment, with different treatments until day 50 of gestation. From day 51 of gestation until weaning, all the animals (ewes and lambs) were housed in a common pen. After weaning, lambs were housed in group pens (5 pens per treatment, three to five per pen). The lambs ran maze tests on weeks five and seven after weaning to evaluate cognitive ability. The maze contained two trap zones and had the pen conspecific lambs at the end of the maze. The measurements were the times to solve the traps and the total time to complete the maze. Data were analyzed using a mixed procedure considering the 2×2 factorial arrangement of treatments. There was a MS × OS × time interaction for the time to complete the maze (P = 0.02). Lambs receiving a different type of fatty acid supplementation during gestation than post-weaning took less time to complete the maze on the second relative to the first day compared with the lambs fed the same type of fatty acids during gestation and growing. In conclusion, combining different fatty acids during different life stages may improve lambs' cognitive abilities.

Maternal high-dose docosahexaenoic acid supplementation and neurodevelopment at 5 Years of preterm children

Background & AimsDocosahexaenoic acid (DHA) is the most abundant omega-3 fatty acid in the brain and is accumulated by the fetal brain during the last trimester of pregnancy. Our objective was to determine whether high-dose DHA supplementation during the neonatal period, vs. placebo, improves behavioral functioning at 5 years in children born very preterm. MethodsThis is a follow-up at 5 years corrected age of a subset of children who participated in a multicenter randomized controlled trial. The participants received a high-dose DHA supplementation, or a placebo, through maternal breast milk until 36 weeks’ postmenstrual age. Primary outcome was child behavioral functioning, assessed by the Total Difficulties Score from the Strengths and Difficulties Questionnaire (SDQ). Secondary outcomes included behavioral scores from the SDQ, executive functions assessment and global developmental performance. Neurodevelopmental outcomes were assessed through interviews with parents. Mean differences between DHA and placebo groups were estimated using mixed linear models. Subgroup analyses were conducted for sex and gestational age (GA) at birth. ResultsAmong 177 eligible children, 132 (74.6%) completed neurodevelopmental assessment at 5 years (DHA, N=64, placebo, N=68). Total Difficulties Score did not differ between the DHA and placebo groups (mean differences, -0.9 [95% confidence interval, -2.7 to 0.8], P=0.30), nor any of the secondary outcomes. There was no significant interaction between treatment groups and sex, nor GA, for the primary outcome. However, significant interactions between treatment groups and sex or GA were found for some secondary outcomes. ConclusionsIn very preterm infants, high-dose DHA supplementation did not improve behavioral functioning at 5 years. Clinical Trial RegistrationClinicalTrials.gov, NCT02371460, https://clinicaltrials.gov/study/NCT02371460

Maternal Nutrition and Human Milk Nutrients

Abstract Purpose: To explore the influence of maternal nutrition factors, including body mass index, nutritional supplementation, and dietary intake during the breastfeeding period, on macro and micronutrient composition in human milk. Study Design and Methods: We conducted a scoping review using the PRISMA-ScR checklist, initially identifying 5,984 original studies published in the English language from PubMed, Scopus, and Web of Science that presented findings on the association of maternal nutritional factors on human milk nutrient composition. After screening the title and abstract, we selected 69 studies for full review, including 3 studies found through checking reference lists. After full review, we included 23 studies in this scoping review. Results: Most studies found maternal body mass index and supplement consumption affected human milk macro and micronutrient composition, whereas inconsistent results were found on the relationship between maternal diet and human milk nutrients. Methodologies varied substantially across studies, especially for milk sample collection methods and maternal nutrition assessments. Clinical implications: Maternal nutrition factors may affect levels of human milk nutrients, requiring maternal nutrition monitoring during breastfeeding. However, given the considerable variability in the results between studies and methodological approaches, further studies should use standardized and validated procedures to strengthen the findings on this topic.

Maternal ketone supplementation throughout gestation improves neonatal cardiac dysfunction caused by perinatal iron deficiency.

Iron deficiency (ID) is common during gestation and in early infancy and has been shown to adversely affect cardiac development and function, which could lead to lasting cardiovascular consequences. Ketone supplementation has been shown to confer cardioprotective effects in numerous disease models. Here, we tested the hypothesis that maternal ketone supplementation during gestation would mitigate cardiac dysfunction in ID neonates. Female Sprague-Dawley rats were fed an iron-restricted or iron-replete diet before and throughout pregnancy. Throughout gestation, iron-restricted dams were given either a daily subcutaneous injection of ketone solution (containing β-hydroxybutyrate [βOHB]) or saline (vehicle). Neonatal offspring cardiac function was assessed by echocardiography at postnatal days (PD)3 and 13. Hearts and livers were collected post-mortem for assessments of mitochondrial function and gene expression profiles of markers oxidative stress and inflammation. Maternal iron restriction caused neonatal anemia and asymmetric growth restriction at all time points assessed, and maternal βOHB treatment had no effect on these outcomes. Echocardiography revealed reduced ejection fraction despite enlarged hearts (relative to body weight) in ID offspring, resulting in impaired oxygen delivery, which was attenuated by maternal βOHB supplementation. Further, maternal ketone supplementation affected biochemical markers of mitochondrial function, oxidative stress and inflammation in hearts of neonates, implicating these pathways in the protective effects conferred by βOHB. In summary, βOHB supplementation confers protection against cardiac dysfunction in ID neonates and could have implications for the treatment of anemic babies.

Effect of heat stress in the first 1000 days of life on fetal and infant growth: a secondary analysis of the ENID randomised controlled trial

The intersecting crises of climate change, food insecurity, and undernutrition disproportionately affect children. Understanding the effect of heat on growth from conception to 2 years of age is important because of mortality and morbidity implications in the near term and over the life course. In this secondary analysis, we used longitudinal pregnancy cohort data from the Early Nutrition and Immunity Development (ENID) randomised controlled trial in West Kiang, The Gambia, which occurred between Jan 20, 2010, and Feb 10, 2015. The ENID trial assessed micronutrient supplementation in the first 1000 days of life starting from 20 weeks' gestation, during which anthropometric measurements were collected prospectively. We used multivariable linear regression to assess the effect of heat stress (defined by Universal Thermal Climate Index [UTCI]) on intrauterine growth restriction based on length-for-gestational age Z score (LGAZ), weight-for-gestational age Z score (WGAZ), and head circumference-for-gestational age Z score (HCGAZ) at birth, and assessed for effect modification of supplement intervention on the relationship between heat stress and infant anthropometry. We used multivariable, multilevel linear regression to evaluate the effect of heat stress on infant growth postnatally based on weight-for-height Z score (WHZ), weight-for-age Z score (WAZ), and height-for-age Z score (HAZ) from 0 to 2 years of age. Complete data were available for 668 livebirth outcomes (329 [49%] female infants and 339 [51%] male infants). With each 1°C increase in mean daily maximum UTCI exposure, in the first trimester, we observed a reduction in WGAZ (-0·04 [95% CI -0·09 to 0·00]), whereas in the third trimester, we observed an increase in HCGAZ (0·06 [95% CI 0·00 to 0·12]), although 95% CIs included 0. Maternal protein-energy supplementation in the third trimester was associated with reduced WGAZ (-0·16 [-0·30 to -0·02]) with each 1°C increase in mean daily maximum UTCI exposure, while no effect of heat stress on WGAZ was found with either standard care (iron and folate) or multiple micronutrient supplementation. For the postnatal analysis, complete anthropometric data at 2 years were available for 645 infants (316 [49%] female infants and 329 [51%] male infants). Postnatally, heat stress effect varied by infant age, with infants aged 6-18 months being the most affected. In infants aged 12 months exposed to a mean daily UTCI of 30°C (preceding 90-day period) versus 25°C UTCI, we observed reductions in mean WHZ (-0·43 [95% CI -0·57 to -0·29]) and mean WAZ (-0·35 [95% CI -0·45 to -0·26]). We observed a marginal increase in HAZ with increasing heat stress exposure at age 6 months, but no effect at older ages. Our results suggest that heat stress impacts prenatal and postnatal growth up to 2 years of age but sensitivity might vary by age. In the context of a rapidly warming planet, these findings could have short-term and long-term health effects for the individual, and immediate and future implications for public child health. Wellcome Trust.

Selenium nanoparticles affect chicken offspring's intestinal health better than other selenium sources

This study aimed to assess the effects of maternal diets containing various selenium (Se) sources on the intestinal mucosal function in the jejunum of chicken offspring. A total of 630, 18-wk-old Hy-Line Grey hens and 70 18-wk-old Hy-Line Grey breeders were randomly allocated into 7 groups, with 5 replicates in each group (18 hens and tow roosters). After 4 wk of Se depletion, the birds were fed either a nonsupplemented basal diet (control) or the same basal diet supplemented with 0.15 mg/kg selenium nanoparticles (Nano-Se), 0.30 mg/kg Nano-Se, 0.30 mg/kg selenocysteine (Sec), 0.30 mg/kg sodium selenite (SS), 0.30 mg/kg selenomethionine (SeMet), or 0.15 mg/kg Nano-Se + 0.15 mg/kg Sec, for 8 wk. Frtilized eggs were collected and incubated during the final week of the experiment. Jejunal tissues from embryonic d 18 and the hatch day were collected for analysis, and the 7-d survival rate of the offspring was recorded. Compared to the control, the maternal diet of 0.30 mg/kg Nano-Se, 0.30 mg/kg Sec, and 0.30 mg/kg SeMet significantly increased the survival of 7-day-old offspring (P < 0.05). The maternal diet supplemented with 0.30 mg/kg Nano-Se significantly increased intestinal villus height and the villus height/crypt depth ratio in chicks at embryonic d 18 and in 1-day-old (P < 0.05). The maternal diet containing 0.30 mg/kg Nano-Se and Sec increased the mRNA expression levels of tight junction proteins in 1-day-old offspring (P < 0.05). Supplemental 0.30 mg/kg Nano-Se significantly increased the mRNA expression levels of marker genes in intestinal enteroendocrine, stem, and Paneth cells (P < 0.05). In 1-day-old chicks, the number of intestinal goblet cells, as well as the mRNA expression levels of intestinal mucin2 (Muc2) and goblet cell differentiation factors (Spdef and C-myc), were the highest in diets supplemented with 0.30 mg/kg Nano-Se. Moreover, the expression levels of intestinal Muc2 and Spdef in chicks at embryonic d 18 was the highest with 0.30 mg/kg Nano-Se supplementation (P < 0.05). Supplementing with 0.30 mg/kg Nano-Se significantly reduced reactive oxygen species levels and decreased the mRNA expression levels of apoptosis-related genes in 1-day-old chicks (P < 0.05). Additionally, 0.30 mg/kg Nano-Se supplementation significantly down-regulated NLRP3 pathway gene expression in 1-day-old chicks (P < 0.05). In conclusion, maternal dietary supplementation with Nano-Se improved jejunal microarchitecture, antioxidant levels, and the expression of tight-junction protein in chicken offspring along with supporting goblet cell development by inhibiting the NLRP3 signaling pathway.

De-implementation of Routine Maternal Oxygen Supplementation for Intrauterine Fetal Resuscitation: A Retrospective Cohort Study.

Current practice guidelines for laboring patients with category II intrapartum tracings recommend maternal oxygen supplementation despite emerging randomized data challenging its benefit and utility. We aim to validate that de-implementing maternal oxygen supplementation for fetal resuscitation did not increase the risk of neonatal acidemia in a real-world setting. This is a retrospective observational study conducted at a single tertiary care center from January 2019 to June 2021. All laboring deliveries during the study period was reviewed and eligible participants included singleton or twin pregnancies between 23-42 weeks gestational age with persistent category II tracings. Known major fetal anomalies, contraindications to labor, and maternal indication for O2 supplementation, including active COVID-19, were excluded. Cohorts were allocated based on time of delivery. Those occurring prior to our hospital policy change identified as historical controls and deliveries after April 1, 2020, as the post-de-implementation cohort. Primary outcome was fetal acidemia, defined as umbilical cord pH < 7.2. Secondary outcomes included severe acidemia (pH < 7.0), 5-minute Apgar score < 4 and neonatal intensive care admission. Regression analyses controlling for known variables associated with neonatal acidemia generated adjusted odds ratios with 95% confidence intervals. Among 9088 deliveries during the study period, 1162 tracings were flagged as persistent category II, including 681 (59%) in the post-intervention group. The two cohorts had comparable baseline and obstetric characteristics. No difference in neonatal acidemia was observed between the post-de-implementation group and historical controls (13.8% vs 15.4%, aOR 0.87, 95% CI 0.62-1.22). Severe acidemia, 5-minute Apgar < 4 and neonatal intensive care admission were not increased in the post-de-implementation group. De-implementation of routine maternal oxygen supplementation for fetal resuscitation did not increase likelihood for neonatal acidemia in a real-world setting, validating guidelines recommending against the intervention.

Maternal Polyphenols and Offspring Cardiovascular-Kidney-Metabolic Health.

The convergence of cardiovascular, kidney, and metabolic disorders at the pathophysiological level has led to the recognition of cardiovascular-kidney-metabolic (CKM) syndrome, which represents a significant global health challenge. Polyphenols, a group of phytochemicals, have demonstrated potential health-promoting effects. This review highlights the impact of maternal polyphenol supplementation on the CKM health of offspring. Initially, we summarize the interconnections between polyphenols and each aspect of CKM syndrome. We then discuss in vivo studies that have investigated the use of polyphenols during pregnancy and breastfeeding, focusing on their role in preventing CKM syndrome in offspring. Additionally, we explore the common mechanisms underlying the protective effects of maternal polyphenol supplementation. Overall, this review underscores the potential of early-life polyphenol interventions in safeguarding against CKM syndrome in offspring. It emphasizes the importance of continued research to advance our understanding and facilitate the clinical translation of these interventions.

Effect of Purified Resveratrol Butyrate Ester Monomers against Hypertension after Maternal High-Fructose Intake in Adult Offspring.

Offspring hypertension arising from adverse maternal conditions can be mitigated through dietary nutritional supplementation, including resveratrol. Previously, we identified derivatives of resveratrol butyrate ester (RBE), specifically 3,4'-di-O-butanoylresveratrol (ED2) and 3-O-butanoylresveratrol (ED4), demonstrating their superior antioxidant capabilities compared to RBE itself. This study sought to assess the protective impact of maternal supplementation with ED2 or ED4 on offspring hypertension in a rat model subjected to a high-fructose (HF) diet during pregnancy and lactation. Female Sprague-Dawley rats were distributed into distinct dietary groups throughout pregnancy and lactation: (1) standard chow; (2) HF diet (60%); (3) HF diet supplemented with ED2 (25 mg/L); and (4) HF diet supplemented with ED4 (25 mg/L). Male offspring were euthanized at the age of 12 weeks. The maternal HF diet induced hypertension in the offspring, which was mitigated by perinatal supplementation with either ED2 or ED4. These protective effects were attributed to the antioxidant properties of ED2 and ED4, resulting in an increased availability of nitric oxide (NO). Additionally, supplementation with ED2 was connected to an increased abundance of Bifidobacterium and Clostridium genera, which was accompanied by a decrease in Angelakisella and Christensenella. On the other hand, ED4 supplementation shielded rat offspring from hypertension by elevating concentrations of short-chain fatty acids (SCFAs) and their receptors while reducing trimethylamine-N-oxide (TMAO) levels. These findings highlight the potential of purified RBE monomers, ED2 and ED4, as preventive measures against hypertension resulting from a maternal high-fructose diet. Further research is warranted to explore their clinical applications based on these promising results.

PSV-13 Betaine supplementation and nutrient restriction during gestation: Influences on growth in fetal sheep offspring

Abstract Restricted nutrition during gestation can reduce offspring productivity. Supplementation of betaine, a methyl donor, promotes fetal growth and liver function. We hypothesized that nutrient restriction during gestation impairs growth, including organ weights and muscle mass, while betaine supplementation would alleviate these negative effects. To determine if maternal betaine supplementation during gestation would improve growth of offspring of restricted-fed dams, multiparous Dorset ewes (n = 47) were estrus synchronized and bred to one of three rams. Ewes confirmed pregnant with twins (n = 32) and singletons (n = 15) were randomly assigned to one of four diets [100% NRC requirements (CON), 60% NRC (RES), CON+betaine (CON+BET; 2 g/d), and RES+BET] from d 30 to 130 of gestation. Among the twins, there were 27 males (CON-8, RES-5, CON+BET-5, and RES+BET-9) and 37 females (CON-8, RES-9, CON+BET-11, and RES+BET-9). Within singletons, there were 7 males (CON-2, RES-2, CON+BET-2, and RES+BET-1) and 8 females (CON-3, RES-1, CON+BET-1, and RES+BET-3). Dam body weight (BW) was measured weekly from d 30 to d 130 of gestation, and diet adjusted accordingly. Dams were euthanized at d 130 of gestation and fetal BW and tissue weights were collected. Data were analyzed using RStudio with P ≤ 0.05 considered significant and 0.05 &amp;lt; P ≤ 0.10 as tendency. At d 130, dams carrying twin fetuses in the CON group were 11.3% and 19.1% heavier than RES and RES+BET dams, respectively (P ≤ 0.05), and CON+BET dams were 18.4% and 10.5% heavier than RES and BET+RES dams, respectively (P ≤ 0.07). However, dams with singletons showed no significant difference in BW (P ≥ 0.37). Regarding fetal BW for singletons, RES fetuses (3.80 ± 0.28kg) were lighter than CON (4.60 ± 0.21kg), CON+BET (4.72 ± 0.27kg), and RES+BET (4.59 ± 0.24kg; P ≤ 0.03). Whereas in twins, RES+BET fetuses (3.19 ± 0.11kg) were lighter than CON (3.68 ± 0.12kg), RES (3.73 ± 0.14kg), and CON+BET (3.60 ± 0.13kg; P ≤ 0.02). In all fetuses, the livers of male RES (28.0 ± 1.49g) and male RES+BET (27.7 ± 1.44g) tended to be heavier than those of female RES+BET (24.5 ± 1.19g; P ≤ 0.07). In terms of muscle mass, female CON+BET (9.33 ± 0.43g) fetuses tended to have greater longissimus muscle (LM) mass compared with female CON (8.30 ± 0.35; P = 0.06), whereas male RES (9.06 ± 0.44g) tended to have heavier LM than male CON+BET (8.02 ± 0.43g; P = 0.09). There were no observed effects of diet, fetal sex, or fetal number on the weights of heart, kidney, perirenal fat, pancreas, semitendinosus muscle, and triceps brachii muscle (P ≥ 0.11). These findings suggest that betaine supplementation may have a significant role in improving fetal BW in singleton pregnancies, with variable effects in twins. Additionally, betaine supplementation may have sex-specific effects on muscle development.

PSLBII-17 Supplementation with organic versus inorganic selenium during pregnancy to support ewe and lamb health

Abstract Selenium (Se) is essential for optimal ovine health and production, and sheep raised on Se-deficient soils can be vulnerable to Se deficiencies that can affect immune function. Organic or inorganic forms of Se supplementation can remedy these consequences. While inorganic Se is less costly, organic Se is more bioavailable and may be more efficient in providing Se to ewes and lambs. The objectives of this study were to determine how organic versus inorganic Se supplementation affects ewe Se status, Se transfer from ewes to lambs, and the antibody-mediated immune response and dermal hypersensitivity response (DHR) of ewes and their lambs. Dorset-Rideau ewes (n = 100) were enrolled in a randomized complete block design study. From gestation d (gd) 110 to postpartum d (ppd) 50, ewes were fed either a Se-deficient diet and supplemented with no Se, 0.3 mg inorganic Se, or 0.3 mg or 0.6 mg organic Se. Sera were collected on gd 110, 130, 140, and ppd 10 and 50 to determine ewe Se status. On gd 110 and 120, ewes received an intramuscular injection of 0.5 mg ovalbumin (OVA) antigen, and on gd 130 the DHR to OVA was assessed by measuring change in skinfold thickness 0, 6, 24 and 48 h post intradermal injection. To measure the transfer of Se from ewe to lamb, a subset of lambs was euthanized at ppd 10, and longissimus dorsi muscle samples were collected and analyzed for Se content. On ppd 20 and 30, lambs received an intramuscular injection of 0.5 mg hen egg white lysozyme (HEWL) antigen, and on ppd 40 the DHR to HEWL was assessed using the aforementioned protocol. Analysis of ewe sera showed a positive correlation between organic Se supplementation and greater Se concentrations (P &amp;lt; 0.01). Moreover, statistical analyses of the DHR results using a generalized least squares linear model (RStudio) indicate that Se supplementation increased the immune response compared with the non-supplemented ewes (P &amp;lt; 0.01). However, no significant differences between organic and inorganic Se supplementation were found. In lambs, greater ewe Se supplementation resulted in greater Se muscle content (P &amp;gt; 0.01). and organic Se supplementation to ewes significantly increased lamb Se muscle content compared with inorganic Se supplementation (P &amp;gt; 0.01). Finally, analyses of the lamb DHR showed that maternal organic Se supplementation improved the lamb immune response compared with the control group (P &amp;gt; 0.05). Therefore, organic Se supplementation optimally enhances ewe and lamb Se status and their adaptive immune response compared with the inorganic and control groups. This knowledge will guide optimal ewe Se-supplementation choices during pregnancy and postpartum, thus promoting lamb and ewe health.

PSI-6 Early life programming of the bovine jejunum function in response to maternal vitamin and mineral supplementation

Abstract Despite the increased appreciation of the involvement of maternal nutrition in fetal development, its effects on jejunum programming remain largely unexplored. Here, we investigated the impact of maternal vitamin and mineral supplementation throughout gestation on the differential gene expression and underlying biological pathways in the jejunum of neonatal calves. For this, beginning 60 d before breeding and continuing throughout gestation, crossbred Angus heifers (n = 14) were fed either a basal diet (CON; n = 7) or the basal diet plus 113 g•heifer-1•d-1 of VTM supplement (VTM; n = 7). All heifers were gestating female calves, which were euthanized 30 h after birth. Samples of jejunum mucosa were collected, stored at -80°C, then subjected to total RNA isolation and RNA sequencing. After quality control, the reads were mapped using STAR aligner and differentially expressed genes (DEGs) were identified using DESeq2. Maternal VTM supplementation did not affect calf organ mass, including jejunum weight. However, high-resolution respirometry analysis revealed greater mitochondrial efficiency in jejunum of calves from VTM supplemented dams. Additionally, we identified 528 DEGs between the VTM and CON calves (P-value ≤ 0.05 and |log2FC| &amp;gt; 0.5). Among them, the genes IGFBP2 and IGFBP6, which are key genes in insulin pathway and involved in regulation of insulin-like growth factors (IGF), IGF transport, and uptake, were upregulated in the VTM group. Additional pathways were identified using ShinyGO, which included the pancreatic secretion pathway, over-represented by genes such as PLCB1, CCK, and SLC26A3. The gene PLCB1 has been associated with feed efficiency, growth, and carcass traits in multiple species. Likewise, the SLC26A3 gene encodes a key intestinal chloride anion exchanger associated with enhanced feed efficiency in cattle. Genes encoding signaling molecules involved with immune response, T cell activation, and defense response were also among the DEGs upregulated in the VTM calves, including the TNFSF18 and TNFRSF4 genes. Our findings suggest that maternal prenatal vitamin and mineral supplementation throughout gestation affects the expression of genes involved in the jejunum function of offspring at a neonatal time point. The long-term consequences of these changes, however, warrant further investigation.

288 Maternal fatty acid supplementation and its impact on dam and offspring performance

Abstract Fatty acid supplementation has multiple benefits to the offspring when supplemented to the dam during pregnancy; limited to no benefits to the dam have been documented. We hypothesized that maternal fatty acid supplementation during pregnancy would result in improved body weight (BW) and body condition score (BCS) in the ewes and improve lamb growth until weaning and male offspring growth following weaning when ewes were supplemented fatty acids. On d -8 of the study (35 d of gestation), all ewes were weighed, BCS was collected, and pregnancy status determined. Pregnant Targhee ewes (n = 83) were assigned to a treatment group based on age, BW, and BCS, to one of four treatment gr: 1) 22 g/ewe daily of Ca salts of saturated and monosaturated fatty acids based on palmitic and oleic acids (CON; EnerGII, Virtus Nutrition, LLC, Corcoran, CA); 2) 22 g/ewe daily of Ca salts of PUFA based on eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids (ɷ-3, Strata; Virtus Nutrition LLC); 3) 22 g/ewe daily of Ca salts of PUFA based on linoleic acids (ɷ-6, Prequel; Virtus Nutrition LLC); or 4) 11 g/ewe of Ca-salts enriched with EPA+DHA (Strata) and 11 g/ewe of Ca-salts enriched with linoleic acid (Strata) daily (ɷ-3 + 6; Virtus Nutrition LLC). Fatty acid supplementation occurred from d 0 until d 88 of the study, and all ewes were fed grass hay. Ewe BW and BCS were recorded at d -8, 51, 93, and 240 of the study. Twenty-four hours after birth, lamb sex was identified and weighed (n = 136 lamb; CON = 33; ɷ-3 = 32; ɷ-6 = 36; ɷ-3 + 6 = 35). Lambs were weighed at d 175 and 240 (weaning) of the study (n = 86; CON = 22; ɷ-3 = 22; ɷ-6 = 21; ɷ-3 + 6 = 21). Body weight, BCS, and scrotal circumference (SC) were collected on all ram lambs at d 352, 380, and 408. No differences were observed in ewe BW or BCS at d -8, 51, or 93 of the study (P ≥ 0.26) between the treatment groups (Table 1). A treatment × day interaction was observed at d 240 of the study when ɷ-6 ewes had a greater (P = 0.03) BCS compared with group cohorts. No differences in lamb birth weight, lamb weight or average daily gain at d 175 or 240 of the study between treatment groups (P ≥ 0.25; Table 2). No differences were reported in ram lamb BW, BCS, or SC at d 352, 380, and 408 (P ≥ 0.31; Table 3). These results indicate that maternal fatty acid supplementation alters ewe BCS at the time of weaning; however, supplementation does not impact lamb growth from birth until weaning or ram lamb growth and scrotal circumference.

255 Awardee Talk: Nutritional management to optimize cow-calf production in Southeast

Abstract Nearly one-half of beef cows in the United States are located in southern states where cow-calf operations predominate. Grazing management in cow-calf systems can be affected by environmental and seasonal conditions, often leading to nutrient deficiency, particularly during late gestation of beef females. Maternal nutrition during the last trimester of gestation can influence offspring development and health, and can be explored to optimize maternal and progeny performance. The objective of this presentation is to share nutritional and management strategies for pregnant beef cows and their long-term effects on offspring growth and physiology. Study 1 investigated the effects of timing of maternal protein supplementation during all last trimester of gestation (LATE84), only the first 42 d of last trimester of gestation (LATE42), or no prepartum supplementation (NOSUP) on offspring pre- and post-weaning performance. At weaning, LATE84 calves were the heaviest, followed by LATE42, and NOSUP (P ≤ 0.05). Steer serum parainfluenza-3 titers were greater (P = 0.03) for LATE42 vs. NOSUP and tended to be greater for LATE84 (P = 0.10) vs. NOSUP steers. Marbling and the proportion of steers grading choice were greater (P ≤ 0.04) for LATE42 vs. NOSUP, and intermediate for LATE84. Study 2 evaluated the effects of frequency of maternal protein supplementation on offspring pre-weaning growth. Cows received the same weekly amount of supplement (7 kg·cow⁻¹·wk⁻¹) but with different frequencies: once a week (1X), three times per week (3X), every day (7X), or no prepartum supplementation (NOSUP) during the last 80 d of gestation. At weaning, calves born from 7X cows were the heaviest (P ≤ 0.05), followed by 3X and 1X, which did not differ between them (P = 0.54), and NOSUP calves were the lightest (P ≤ 0.05). Study 3 evaluated the use of monensin supplementation during the last 77 d of gestation and its impacts on offspring performance. Treatments consisted of no prepartum supplementation (NOSUP), supplementation of dried distillers grains at 1 kg·cow⁻¹·d⁻¹ added with 0 (SUP) or 200 mg/d of monensin (SUPMO). At weaning, SUPMO calves were the heaviest (P ≤ 0.05), SUP intermediate, and NOSUP were the lightest. Experiment 4 consisted of pregnant heifers receiving the supplementation of 1 kg/d of soybean hulls dry matter added (BAC) or not (CON) with a Bacillus-based DFM mixture during late gestation (d 0 to 139) and early lactation (d 139 to 242). Post-weaning body weight gain and indicators of humoral immune response post-vaccination were greater for BAC vs. CON calves (P ≤ 0.05). Therefore, changing the time and frequency of supplementation, and the use of additives and probiotics during late gestation of beef females are effective alternatives to improve offspring pre- and post-weaning growth and immune response.

127 Effects of maternal pre- and post-partum supplementation of a Bacillus-based DFM on plasma metabolome profile of Bos indicus-influenced heifers and their offspring

Abstract This study evaluated the effects of maternal supplementation during pre- and postpartum of a Bacillus-based direct-fed microbial (DFM) on plasma metabolome of Bos indicus-influenced cow-calf pairs. On d 0, 72 pregnant Brangus crossbred beef heifers (20 to 22 mo of age) were stratified by their initial body weight (BW; 431 ± 31 kg) and body condition score (BCS; 6.0 ± 0.36), and randomly allocated into 1 of 12 bahiagrass pastures (1 ha and 6 heifers/pasture). Treatments were randomly assigned to pastures (6 pastures/treatment) and consisted of heifers supplemented with 1 kg/d of soybean hulls dry matter added (BAC) or not (CON) with a Bacillus-based DFM mixture (Bovacillus; Chr. Hansen A/S, Hørsholm, Denmark) from d 0 to 242 (139 ± 4 d prepartum to 104 ± 4 d postpartum). Calves were weaned on d 242 (96 ± 30 d of age) and then allocated into 1 of 12 drylot pens and limit-fed the same concentrate at 3.25% of BW until day 319. On d 271 and 287, calves were vaccinated against pathogens associated with bovine respiratory disease and Clostridium. Blood samples were collected from all heifers on d 0 and 63 and from all calves on d 271, 274, and 287 to determine the plasma concentration of metabolites using liquid chromatography. The PLS-DA revealed a clear separation of plasma metabolome profile of BAC and CON heifers and offspring. For the heifer metabolome, 66.5% of the treatment separation on d 63 was explained using 3 components (R2 = 0.96), and BAC heifers had increased (P ≤ 0.05) plasma concentration of 17 metabolites, including phosphatidylcholines and amino acids related classes, but decreased (P ≤ 0.05) plasma concentration of 4 metabolites from triglycerides class compared with CON heifers. For the calf metabolome, 45.6 (R2 = 0.95), 56.7 (R2 = 0.95), and 61.3% (R2 = 0.99) of the treatment separation on d 271, 274, and 287, respectively, were explained using 3 components. Plasma concentrations of 9, 10, and 28 metabolites associated with protein and fatty acid metabolism increased (P ≤ 0.05) in BAC vs. CON calves on d 271, 274, and 287, respectively. Compared with CON, BAC calves had increased (P ≤ 0.05) concentration of metabolites from phosphatidylcholines class all days, from amino acids related class on d 274 and 287, and from triglycerides class on d 287. Plasma concentrations of 3 and 6 metabolites from triglycerides class decreased (P ≤ 0.05) in BAC vs. CON calves on d 271 and 274, respectively. Thus, maternal supplementation of Bacillus-based DFM altered the plasma metabolome of heifers and their calves, leading to increased plasma concentrations of phosphatidylcholine and amino acids related classes in heifers and calves, but fluctuating effects on triglycerides class concentrations in calves.

172 Impact of maternal and postnatal 25-hydroxycholecalciferol supplementation on porcine and avian satellite cell mitotic activity and skeletal muscle growth characteristics

Abstract Vitamin D is an essential micronutrient most well-known for regulating calcium and phosphorus homeostasis and bone mineralization. However, over the last 20 yr, the extra-skeletal, pleotropic effects of vitamin D and its metabolites have gained greater attention. For livestock species reared indoors, vitamin D supplementation is especially important and commonly achieved by dietary addition of cholecalciferol, also known as vitamin D3 (D3). Cholecalciferol is hydroxylated in the liver to produce the circulating form, 25-hydroxycholecalciferol (25OHD3), also called calcidiol. Circulating 25OHD3 is subsequently converted to 1α,25-hydroxycholecalciferol (1,25OHD3) which binds a nuclear receptor found in many tissues, including skeletal muscle, to elicit its effects. This presentation will focus on the recent work regarding the effects of both maternal and postnatal 25OHD3 supplementation on porcine and avian satellite cell mitotic activity and skeletal muscle growth characteristics. Feeding broilers 25OHD3 posthatch results in a satellite cell-mediated skeletal muscle hypertrophic response in the fast-twitch pectoralis major but not the slow-twitch biceps femoris. Maternal dietary supplementation of gilts and hens with 25OHD3 in place of the majority of D3 increases circulating 25OHD3 concentrations in both dams and their offspring. The improvements in vitamin D status coincide with positive effects on skeletal muscle fiber number in fetal piglets as well as satellite cell mitotic activity and hypertrophic growth of fibers in both swine and broiler chickens. Though, interestingly, combining maternal and posthatch 25OHD3 supplementation in broilers does not appear to produce additive or synergistic effects on SC-mediated muscle growth. However, increasing circulating concentrations of 25OHD3 by supplementing either the maternal or postnatal diet with 25OHD3 has positive effects on meat yield in both porcine and avian models. Overall, these data shed light on the cellular mechanisms behind the efficacy of this vitamin D supplementation strategy using commercially available 25OHD3 sources in increasing meat yield and yet, leaves enough unanswered questions remaining to warrant further exploration.

24 Maternal supplementation with different sources of trace minerals to beef cattle and its effects on postweaning responses of the offspring

Abstract The goal of this trial was to evaluate the effects of different sources of trace minerals on fetal programing and their impact on cow reproductive and postweaning offspring performance until slaughter. Seventy-two non-lactating, pregnant Angus cows [initial body weight (BW) = 637 ± 13 kg; body condition score (BCS) = 5.5 ± 0.07; and age = 6.1 ± 0.57; exposed to artificial insemination (AI) = 54 and bull = 18] were ranked by BW and BCS and assigned to receive a supplement containing: 1) Cu, Mn, and Zn from sulfate source (INR; n = 24), 2) Cu, Mn, and Zn from organic source (ORG; n = 24), or 3) Cu, Mn, and Zn from hydroxychloride source (HXD; n = 24). From d 0 to calving, cows remained on the same pasture and were fed individually three times a week. After calving, pairs were assigned to the general herd management, including inorganic mineral supplementation. Calves were weaned at 6 mo of age and were managed as a single group on a backgrounding period for 85 d. Calf blood samples were collected on d -15, 0, 4, 8, 15, 20, and 28 relative to weaning to evaluate stress-related markers. After this period, calves were fed to finish in a commercial feedyard. Cattle were then harvested, and carcass data were recorded. Though not the focus of this trial, there was a numerical improvement (P = 0.22) in overall subsequent pregnancy rate for the HDX (92.1%) compared with the ING (74.3%) and ORG (75.2%) cows. Also, the HDX had a tendency (P = 0.07) for improvement in liver Cu status compared with the other treatments. At weaning, no treatment differences were detected (P ≥ 0.88) in calf weaning BW and average daily gain from weaning to feedyard receiving. There were no differences (P ≥ 0.22) in the blood stress-related enzymes and metabolites. However, there was a tendency for a decrease in plasma haptoglobin at day 15 post-weaning (P = 0.07) for the calves from HDX supplemented cows relative to other treatments (Figure 1). Which might indicate potential amelioration of inflammation for the calves from cows supplemented with HDX trace minerals during pregnancy. Feedyard growth performance were similar (P ≥ 0.35) across treatments for the offspring (Table 1). No treatment effects were detected (P ≥ 0.17) for carcass traits between treatments (Table 2). Overall, different sources of trace minerals supplemented to late gestating beef cows yield similar effects on offspring performance from weaning and background period until slaughter, whereas a potential amelioration of inflammation was observed in calves born to HDX cows.

Effects of maternal dietary supplementation with antioxidants on clinical status of mares and their foal

BackgroundThe peripartum period constitutes a delicate physiological moment in mares showing a transient state of oxidative stress. Diet supplementation with antioxidants during pregnancy in women appears to have a beneficial effect on mother and neonate health. The aim of this work was to evaluate the effects of diet supplementation with a commercial product containing a mix of antioxidants (Oxyliver®, Candioli) on the length of gestation, weight, and haemato-biochemical parameters in Italian Salernitano mares and their newborn foals. Eight late-term pregnant mares were randomly divided into two groups: Antiox group receiving 30 g/day of antioxidants, and Car group receiving the same amount of carrot powder, from 290 to 320 days of gestation. The following parameters were evaluated in mares: weight, colostrum composition, haemato-biochemical parameters, progesterone, and cortisol blood concentrations, along with blood oxidant/antioxidant status. Assessments were conducted at specific time points: immediately before the start of diet supplementation (T0), 15 days after (T1), at the end of diet supplementation (T2), within 8 h after parturition (T3), and 10 days post-partum (T4). Foal parameters such as weight, haemato-biochemical values, cortisol concentration, and blood oxidative stress variables were assessed within 8 h of birth (TF0) and at 10 days of age (TF1).ResultsPregnancy was shorter in the Antiox group (P < 0.05) compared with the Car group; the foals’ weight increase of group Antiox (40%) was higher (P < 0.05) compared to those of the Car group (28.6%). The colostrum of the Antiox group exhibited higher levels of Brix, total solids, protein, nonfat solids, casein, urea, density, free fatty acids, and glucose, while lower levels of fat and lactose were observed compared to the Car group (P < 0.05). Mares’ serum albumin at T1 and T3, creatinine, glucose, total proteins, total bilirubin, AST, and ALT at T3 were lower in Antiox than in the Car group. No significant differences were found in foals.ConclusionsWhile the limited sample size and the potential variability of evaluated parameters, the observed outcomes suggest that Oxyliver® supplementation in mares might safely decrease gestation length and enhance liver function, thus potentially improving colostrum quality and offspring development.

Maternal Supplementation with Dietary Betaine during Late Gestation Increased Ewe Plasma Creatine and Lamb Thermoregulation under Field Conditions.

Twin lamb mortality is a significant economic problem impacting the Australian sheep industry. Maternal betaine supplementation improved lamb vigour and early post-natal survival when ewes and lambs were housed indoors, suggesting that betaine may be beneficial to feed under extensive pasture systems. This study investigated whether maternal betaine supplementation during late gestation would improve Merino twin lamb live weight, thermoregulation, vigour and survival to weaning under field conditions. Ewes received dietary betaine at either 0 g/day (CTL; n = 115) or 4 g/day from day 110 of gestation (dG 110) until ~49 days post-partum (pp) (BET; n = 115). Measures indicative of lamb viability and survival were collected within 4-24 h of birth and at ~49 days pp and ~93 days pp. BET ewes had higher creatine and creatinine concentrations at dG 130 than CTL ewes (p < 0.05). BET lambs had a higher rectal temperature within 4-24 h following birth than CTL lambs (p < 0.05). CTL lambs were heavier at ~49 days pp and grew faster from birth to ~49 days pp than BET lambs (both p < 0.05). The time taken after release from the researcher to first suckling was quicker in the CTL lambs than BET lambs (p < 0.05). This study demonstrated that supplementing betaine increased creatine concentration in twin-bearing ewes and thermoregulatory capacity in neonatal lambs under extensive grazing systems.

Maternal choline supplementation rescues early endosome pathology in basal forebrain cholinergic neurons in the Ts65Dn mouse model of Down syndrome and Alzheimer’s disease

Individuals with DS develop Alzheimer’s disease (AD) neuropathology, including endosomal-lysosomal system abnormalities and degeneration of basal forebrain cholinergic neurons (BFCNs). We investigated whether maternal choline supplementation (MCS) affects early endosome pathology within BFCNs using the Ts65Dn mouse model of DS/AD. Ts65Dn and disomic (2N) offspring from dams administered MCS were analyzed for endosomal pathology at 3–4 months or 10–12 months. Morphometric analysis of early endosome phenotype was performed on individual BFCNs using Imaris. The effects of MCS on the endosomal interactome were interrogated by relative co-expression (RCE) analysis. MCS effectively reduced age- and genotype-associated increases in early endosome number in Ts65Dn and 2N offspring, and prevented increases in early endosome size in Ts65Dn offspring. RCE revealed a loss of interactome cooperativity among endosome genes in Ts65Dn offspring that was restored by MCS. These findings demonstrate MCS rescues early endosome pathology, a driver of septohippocampal circuit dysfunction. The genotype-independent benefits of MCS on endosomal phenotype indicate translational applicability as an early-life therapy for DS as well as other neurodevelopmental/neurodegenerative disorders involving endosomal pathology.